Procter & Gamble Hygiene and Health Care (500459) Q2 25/26 earnings summary

Executive summary

• Unaudited financial results for the quarter and six months ended September 30, 2025, were approved and reviewed by the Board and Audit Committee on November 6, 2025.

• The company changed its financial year-end from June 30 to March 31, making the previous year a nine-month period.

Financial highlights

• Revenue from operations for the quarter ended September 30, 2025, was ₹114,885 lakhs, up from ₹113,273 lakhs in the same quarter last year.

• Profit before tax for the quarter was ₹28,178 lakhs, compared to ₹28,537 lakhs in the same quarter last year.

• Net profit for the quarter was ₹21,190 lakhs, compared to ₹22,136 lakhs in the same quarter last year.

• Earnings per share (EPS) for the quarter was ₹64.65, compared to ₹65.28 in the same quarter last year.

• For the six months ended September 30, 2025, revenue was ₹208,401 lakhs and net profit was ₹40,192 lakhs.

Outlook and guidance

• The company continues to focus on manufacturing, trading, and marketing of health and hygiene products, with no separate segment reporting due to aggregation under Ind AS 108.